Clinical Trial Update: IMPT Dose Escalation for NSCLC (HyDose) [NA]

View source ↗

Summary

Clinical trial update for HyDose, a dose-escalation study of IMPT in non-small cell lung cancer. It is currently recruiting at University Medical Center Groning…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Carcinoma, Non-Small-Cell Lung | NA | Status: RECRUITING